Suven Life Sciences Ltd.

In 2022, Indian companies seem to have followed financial economist and investor Robert Haugen’s philosophy as they added missing bits, strengthened weak spots or built on their strengths for merger a

In 2022, Indian companies seem to have followed financial economist and investor Robert Haugen’s philosophy as they added missing bits, strengthened weak spots or built on their strengths for merger a

H. Lundbeck A/S / Otsuka Pharmaceutical Co. Ltd. ’s and Axsome Therapeutics, Inc. ’ respective Alzheimer’s disease agitation drug candidates, Rexulti and Auvelity, have both hit the bullseye in their

Aceto’s sale of Rising Pharmaceuticals can go ahead, the US Bankruptcy Court has decided, approving a ‘stalking horse’ deal recently concluded between Aceto and Shore Suven Pharma . Under the terms o